Skip to main content
School of Public Health
block W logo University of Washington

Anirban Basu

faculty photo
Professor, Health Services
Professor, Pharmacy (primary appt.)
Adjunct Professor, Economics


Education

PhD   University of Chicago, 2004   (Health Economics, Public Policy)
MS   University of North Carolina (Chapel Hill), 1999   (Biostatistics)
MS   University of Toledo, 1997   (Pharmaceutical Sciences)
BS   Jadavpur University, 1995   (Pharmaceutical Sciences)

Contact Info

email:   basua@uw.edu
web site:   http://faculty.washington.edu/basua/

office:   H-375Q, Health Sciences Building

address:
Magnuson Health Sciences Center
1959 NE Pacific St.
Seattle, WA 98195-7630

campus box:   357630
voice:   206-616-2986
fax:   206-543-3964

About

Anirban Basu's work sits at the intersection of microeconomics, statistics, and health policy. His research focuses on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research.

Currently the Stergachis Family Endowed Professor and Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington, Basu also serves as faculty member in the Department of Health Services and as an adjunct in the Department of Economics. Previously, Basu taught on the faculty of the University of Chicago Department of Medicine, where he remains an external affiliate of the Center for Health and the Social Sciences.

In addition to his position as a faculty research fellow at the National Bureau of Economic Research, Basu is as an associate editor for Health Economics, Journal of Health Economics, and Observational Studies, and has served as panelist or speaker at many economics and health studies conferences, nationally and abroad.


Health econometrics; cost-effectiveness; comparative effectiveness and value of information analyses; quality of life; spill-over effects; substantive focus on cancer, mental health and diabetes
  • HSERV 525
    Advanced Health Services Research Methods III - Causal Inference Using Observational Data


Gautam S, Kachroo S, DeClue RW, Fisher MD, Basu A. Real-world patterns on tumor mutation burden testing in a pan-tumor population. Future Oncol. 2021 Jan 29. doi: 10.2217/fon-2020-1005. [Epub ahead of print]  PMID: 33512239
PubMed
 
DOI
 


Chen S, Graff J, Yun S, Beal B, Ta JT, Bansal A, Carlson JJ, Veenstra DL, Basu A, Devine B. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making. J Manag Care Spec Pharm. 2021 Jan;27(1):95-104. doi: 10.18553/jmcp.2021.27.1.095.  PMID: 33377442
PubMed
 
DOI
 


Wang WJ, Devine B, Bansal A, White HS, Basu A. Meta-analyzing count events over varying durations using the piecewise Poisson model: The case for poststroke seizures. Res Synth Methods. 2020 Nov 1. doi: 10.1002/jrsm.1465. [Epub ahead of print]  PMID: 33131152
PubMed
 
DOI
 


Barthold D, Marcum ZA, Chen S, White L, Ailabouni N, Basu A, Coe NB, Gray SL. Difficulty with Taking Medications Is Associated with Future Diagnosis of Alzheimer's Disease and Related Dementias. J Gen Intern Med. 2020 Oct 9. doi: 10.1007/s11606-020-06279-y. [Epub ahead of print]  PMID: 33037589
PubMed
 
DOI
 


Hendrix N, Regier DA, Chatterjee J, Dhanda DS, Basu A, Veenstra DL, Carlson JJ. Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment. Per Med. 2020 Sep;17(5):389-398. doi: 10.2217/pme-2020-0018. Epub 2020 Aug 17.  PMID: 32804043
PubMed
 
DOI
 


2019
Chair, dissertation committee for Jordan Banks
Exploration of HealthCoin: A Currency to Address US Private Payer Underfunding for Single or Limited Administration Treatments with Long-Term Effectiveness (SLA therapies)

2018
Chair, dissertation committee for Sungchul Park
Understanding unintended consequences of risk adjustment and proposing alternative risk adjustment

2017
Chair, dissertation committee for Benjamin Ely
Antibiotics and acute respiratory tract infections: a policy evaluation of the CDC’s Get Smart about Antibiotics campaign.

Current and Future Costs of Alzheimer's and Dementia Care
National Institutes of Health (NIH)
PI:   Coe           Dates:    7/1/2015 - 6/30/2019

WWAMI Practice Transformation Network
Centers for Medicare and Medicaid Services (CMS)
PI:   Flum           Dates:    5/1/2015 - 4/30/2019

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
National Institutes of Health (NIH)
PI:   Zatzick           Dates:    7/1/2014 - 6/30/2019

Personalized Medicine Economics Research (PriMER)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
PI:   Veenstra           Dates:    10/1/2013 - 9/30/2018

Graduate Certificate in Comparative Effectiveness Research

Comparative effectiveness research is a growing field that aims to generate evidence to improve health care decisions for patients and providers. It examines the benefits and risks of different medical or healthcare interventions, including drugs and medical technology. The results of these comparison studies are used by medical professionals to make better informed healthcare decisions and thereby improve patient care.